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Abstract
Background: Autism Spectrum Disorders (ASD) are phenotypically heterogeneous, characterized by impairments in 
the development of communication and social behaviour and the presence of repetitive behaviour and restricted 
interests. Dissecting the genetic complexity of ASD may require phenotypic data reflecting more detail than is offered 
by a categorical clinical diagnosis. Such data are available from the Social Responsiveness Scale (SRS) which is a 
continuous, quantitative measure of social ability giving scores that range from significant impairment to above 
average ability.
Methods: We present genome-wide results for 64 multiplex and extended families ranging from two to nine 
generations. SRS scores were available from 518 genotyped pedigree subjects, including affected and unaffected 
relatives. Genotypes from the Illumina 6 k single nucleotide polymorphism panel were provided by the Center for 
Inherited Disease Research. Quantitative and qualitative analyses were done using MCLINK, a software package that 
uses Markov chain Monte Carlo (MCMC) methods to perform multilocus linkage analysis on large extended pedigrees.
Results: When analysed as a qualitative trait, linkage occurred in the same locations as in our previous affected-only 
genome scan of these families, with findings on chromosomes 7q31.1-q32.3 [heterogeneity logarithm of the odds 
(HLOD) = 2.91], 15q13.3 (HLOD = 3.64), and 13q12.3 (HLOD = 2.23). Additional positive qualitative results were seen on 
chromosomes 6 and 10 in regions that may be of interest for other neuropsychiatric disorders. When analysed as a 
quantitative trait, results replicated a peak found in an independent sample using quantitative SRS scores on 
chromosome 11p15.1-p15.4 (HLOD = 2.77). Additional positive quantitative results were seen on chromosomes 7, 9, 
and 19.
Conclusions: The SRS linkage peaks reported here substantially overlap with peaks found in our previous affected-only 
genome scan of clinical diagnosis. In addition, we replicated a previous SRS peak in an independent sample. These 
results suggest the SRS is a robust and useful phenotype measure for genetic linkage studies of ASD. Finally, analyses of 
SRS scores revealed linkage peaks overlapping with evidence from other studies of neuropsychiatric diseases. The 
information available from the SRS itself may, therefore, reveal locations for autism susceptibility genes that would not 
otherwise be detected.
Background
Compelling evidence exists to suggest that autism spec-
trum disorder (ASD) has a complex heterogeneous
genetic aetiology [1]. However, the specific nature of the
genetic aetiology is not well understood. This genetic het-
erogeneity is, perhaps, not surprising given the pheno-
typic complexity and range of expression of ASD.
Examining autism-related characteristics along a contin-
uum of expression may yield more insight into the partic-
ular roles played by autism susceptibility genes. In
addition, if ASD characteristics are viewed on a contin-
uum, then clinically unaffected family members can also
contribute information to family genetic studies.
Relatives of individuals with ASD have subclinical traits
related to autism more frequently than the relatives of
controls [2-8]. These subclinical traits can vary in inten-
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sity and have been collectively termed the broader autism
phenotype (BAP). In addition, characteristics of clinically
affected subjects - such as language delay, language defi-
cits, social deficits, repetitive behaviours and insistence
on sameness - have been successfully used to refine and
clarify genetic studies of autism [9-12]. While categorical
diagnostic status has been used successfully to identify
autism linkage regions [1], quantitative measures that
include the BAP provide additional information from
clinically unaffected family members, and also provide
more detailed phenotypic information on affected sub-
jects.
The social, behavioural and communication character-
istics of ASD are common and may be viewed as on a
continuum with possible cutoffs for affected individuals
[13,14]. The social responsiveness scale (SRS) is a quanti-
tative measure of autistic traits with comparable child
and adult versions, ranging continuously from signifi-
cantly impaired to above average [13,15,16]. Several stud-
ies have reported significant familial correlations of
s u bc l i n i c a l  f e a t u r e s  o f  a u t i s m  as  m e as u r ed  b y  t h e  S RS
[17-19], consistent with previous evidence of significant
heritability of the BAP [7]. One previous genome-wide
linkage scan has been done using SRS scores obtained
from children in 99 nuclear families from the Autism
Genetic Resource Exchange [20]. That study included 408
microsatellite markers and two suggestive genetic loci
were identified on chromosomes 11 and 17, with other
possible regions identified on chromosomes 4, 8, and 10.
We report genome-wide SRS linkage results using sin-
gle nucleotide polymorphism (SNP) data genotyped on a
unique resource of large extended and smaller multiplex
AS D fa m ili es  fr om  U ta h. W e ha ve  pr evious l y r eport ed
linkage evidence in these families using clinical diagnos-
tic status and only including information from affected
pedigree members. The current study has two advan-
tages. First, we include additional phenotype information
above and beyond our previous affected-only genome
scan by using the quantitative SRS measure: clinically
unaffected relatives can contribute information to this
analysis. The SRS phenotype therefore adds to our previ-
ous study in our extended pedigrees. Second, we add to
other previous studies of the SRS which focus on nuclear
families. The likely heterogeneity of ASD increases the
value of studies that include extended pedigrees [21,22].
Collections of small families may include cases with many
different susceptibility loci. Subjects affected with ASD
who are members of a large extended family may be more
likely to share the same genetic causes through their com-
mon ancestors. Particularly for rare disease-causing vari-
ation, the type of variation most likely underlying autism
spectrum disorders, extended pedigrees have substan-
tially more power to reveal true findings that designs with
single cases or small families [23]. Once variation has
been found, pedigree members can reveal penetrance of
the variant and specific associations with related pheno-
types. The study of the SRS in pedigrees may be of partic-
ular interest, as recent evidence suggests differences in
the SRS between simplex and multiplex families [24].
Methods
Subjects
Subjects were initially ascertained from 70 pedigrees that
had at least two family members with an ASD. Six fami-
lies did not have sufficient SRS phenotype information
(defined as at least two family members with SRS scores)
and were therefore dropped from this analysis. A total of
629 genotyped subjects from 64 families were used here,
181 of whom were defined as having either a strictly
defined autistic disorder (AD) or a more broadly defined
ASD. Table 1 gives the characteristics of these families
which include 19 large extended pedigrees (6-9 genera-
tions), six families of moderate size (4-5 generations) and
39 smaller families (2-3 generations). The 19 extended
pedigrees were identified or confirmed using the Utah
Population Database (UPDB), a computerized genealogy
database that contains family history information for over
6.5 million individuals who are, for the most part, descen-
dants of the nineteenth century Utah pioneers http://
www.hci.utah.edu/groups/ppr/. Previous studies have
shown low rates of inbreeding within the UPDB [25,26].
Using the UPDB, we were able to identify many distant
family relationships between the individuals with ASD
that were not known to the subjects or their families.
These relationships were kept confidential. This study
has ongoing approval from the University of Utah Institu-
tional Review Board (IRB). All adults participating in the
research signed IRB-approved informed consent docu-
ments. All subjects under the age of 18 signed approved
assent documents and their parents or guardians signed
approved parental permission documents. Subjects in
this study are independent from the Utah subjects who
were contributed to the Autism Genome Project and
studied by Liu et al. [27]. In addition, none of the families
in the current analysis were included in the data set stud-
ied by Duvall et al. [20].
Phenotyping
Families interested in participating were asked to give
questionnaire consent, to give initial information regard-
ing possible exclusion criteria and to complete the Social
Communication Questionnaire (SCQ) [28]. The SCQ was
developed as a parent report measure based on the
Autism Diagnostic Interview-Revised [29]. A cutoff score
of 15 on the SCQ has been shown to have good sensitivity
(0.85) and specificity (0.75) for discriminating ASD from
other diagnoses [30]. Subjects were contacted for possible
inclusion if their SCQ score was above 15 or if they had aCoon et al. Molecular Autism 2010, 1:8
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previous diagnosis of ASD. Subjects were excluded if they
reported medical conditions known to be associated with
autism (tuberous sclerosis, fragile X, neurofibromatosis,
congenital rubella or phenylketonia) or evidence of brain
injury. To the best of our knowledge, given currently
available data, subjects did not have chromosomal anom-
alies that could confound our findings. If subjects were
eligible for the study, they were asked to sign informed
consent for DNA and additional assessments. When pos-
sible, all subjects with a suspected ASD were then given
both the ADI-R and the Autism Diagnostic Observation
Schedule-Generic [31] and study diagnoses were made
using these assessments. For cases where assessments
could not be obtained, the diagnoses were made accord-
ing to Diagnostic and Statistical Manual of Mental Disor-
ders (DSM)-IV criteria by a psychologist trained in
autism assessment (JSM) using all available information
(clinical records, other behavioural data, other question-
naire and interview information).
All available subjects were given the SRS. Completed
questionnaires were obtained from a total of 523 family
members who were genotyped. Completed question-
naires were obtained for 92.1% of index cases, 83.9% of
siblings (affected and unaffected), 87.2% of fathers, 78.8%
of mothers and 73.7% of more extended relatives (grand-
parents, great-grandparents). The child version of the
SRS was completed for 205 subjects and the adult version
was completed by 318 subjects. The child version was
filled out by a parent for almost all cases (203/205;
99.02%). The adult version was usually filled out by a
spouse (236/318; 74.21%) but parents were raters for
adult siblings over age 18 (59/318; 18.6%). Other infor-
mants filled out the remainder of the adult SRS forms
(23/318; 7.2%). No children were rated by a parent with
ASD. However, after surveys were returned, five adult
raters were found to have ASD. Scores from these five rat-
ers (fathers) on their spouses (mothers) were not used for
subsequent analyses, leaving 518 subjects with scores.
There were an additional four children whose parent was
coded as a poor rater on the ADI for under-reporting of
behaviours. While no data regarding rater quality were
available for the SRS directly, the similarity of content
across the ADI and SRS made ratings done by these par-
ents was suspect. Scores for these subjects were therefore
not used in the quantitative analyses of data. For qualita-
tive SRS analysis, data on these subjects were not deleted
because possible under-reporting on the SRS did not
impact upon the SRS category.
Genotyping
Genotyping services were provided by the Center for
Inherited Disease Research (CIDR) using the 6 K single
nucleotide polymorphism (SNP) Illumina Linkage Panel
12, which includes 6090 SNP markers, with an average
genetic coverage of 0.65 cM. There were 46 SNPs who
were dropped due to poor performance, leaving 6044
SNPs. Data from 653 pedigree subjects passed stringent
quality control criteria for initial inclusion in the study
[32]. Of the 629 genotyped subjects in 64 families used in
this study, 518 of had SRS data.
Eliminating linkage disequilibrium (LD) between mark-
ers in linkage studies has been strongly recommended, as
false positive results can occur in the presence of LD [33-
36]. As these studies have shown, increases in type I error
are most dramatic when LD is high and when there are
missing genotypes for parents and other connecting rela-
tives. Recommended thresholds of acceptable LD vary,
Table 1: Description of the Utah autism spectrum disorder (ASD) families.
Type of 
family
No. of 
families
Average No. of 
generations; 
standard deviation 
(SD; range)
Total 
subjects
Average 
No. of 
subjects 
per family; 
SD (range)
Total ASD 
subjects
Average No. of 
ASD subjects per 
family; SD 
(range)
Total No. of 
subjects with 
SRS
Average No. 
of subjects 
per family 
with SRS 
(range)
Large (6-9 
generations)
19 7.89; 0.66 (6 to 9) 328 17.26; 12.92 
(5 to 50)
81 5.22; 2.54 (2 to 9) 254 13.37; 10.32 
(4 to 40)
Moderate (4 
generations)
6 4; 0.00 (4) 85 14.17; 11.34 
(6 to 32)
21 4.00; 3.39 (2 to 9) 70 11.67; 10.21 
(3 to 27)
Small (2-3 
generations)
39 2.28; 0.46
(2 to 3)
216 5.54; 2.40
(2 to 11)
79 2.05; 0.57 (1 to 3) 194 4.97; 2.11
(2 to 11)
Full sample 64 629 181 518
SRS, Social Responsiveness Scale.Coon et al. Molecular Autism 2010, 1:8
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but a pair-wise r2 value of 0.05 between SNPs has now
been supported with extensive simulation studies [34].
Therefore, prior to linkage analysis, we screened all SNPs
for LD using the PLINK software package [37], which
recursively removes SNPs in LD within a sliding window.
We set a window size of 50 SNPs, shifted the window by
five SNPs at each step, and used a variance inflation fac-
tor of 1.5, which is equivalent to a multiple correlation
coefficient  R2 of 0.33 regressed simultaneously over all
SNPs in the selected window. This R2 considers not only
the correlations between SNPs but also between linear
combinations of SNPs [37] and corresponds in our data
to a pair-wise r2 of approximately 0.05. This screening for
LD removed 1207 SNPs. Also, as part of the validation
procedure, we removed 115 SNPs with a minor allele fre-
quency less than 0.10 and 4 SNPs out of Hardy-Weinberg
equilibrium. The total number of SNPs left after this
phase was 4718.
Analyses
We used the genetic map provided by CIDR based on the
deCODE genetic map [38]. Base pair positions were
obtained from the March 2006 human reference
sequence (hg18) assembly. The SRS was first treated as a
qualitative trait. Published cutoff scores [15] were used to
delineate three groups: SRS unaffected (raw score below
54), SRS spectrum (raw score between 54 and 87) and
SRS affected (raw score 87 or above). Subjects who were
missing SRS scores were coded as unknown.
This qualitative phenotype was tested using MCLINK,
a Markov chain Monte Carlo (MCMC) method that
allows for multilocus linkage analysis on large extended
pedigrees [39]. Using blocked Gibbs sampling, MCLINK
generates inheritance matrices for haplotypes of the
markers being analysed and estimates the log-likelihood
function linkage statistics. This method results in the
reconstruction of haplotype configuration for the entire
pedigree structure, allowing for analysis of the full genetic
information available in the pedigree. MCMC methods
therefore maximize the utility of extended pedigree data,
as genetic information increases with the number of mei-
oses in a family [40]. Further, the multipoint analysis
maximizes the genetic information available from the
e n t i r e  m a p  o f  S N P  g e n o t y p e s .  I n  m u l t i p o i n t  a n a l y s e s ,
genetic information increases with the density of the gen-
otypes [41-43] but is not decreased, with exclusion of
markers in high linkage disequilibrium [42]. Internally,
MCLINK runs the analysis five times to ensure a consis-
tent solution. Results from MCLINK have shown a high
degree of similarity to other MCMC linkage methods [44]
and also to exact linkage methods and variance compo-
nents linkage methods as applied to extended pedigrees
[45]. MCLINK has been previously used to identify can-
didate genomic regions for a number of complex diseases
in extended pedigrees [44,46-48]. Allele frequencies for
the MCLINK analysis were estimated using all of the
observed data.
We performed a non-parametric analysis and a general
parametric model-based analysis using simple dominant
and recessive model parameters that reproduced the
reported population frequency of ASD [49]. For the
recessive model, the disease allele frequency was set at
0.05; a penetrance of 0.01, 0.01, 0.5 was assigned to those
with SRS scores in the spectrum category and 0.0014,
0.0014, 0.8 was assigned to those with SRS scores in the
SRS affected category. For the dominant model, the dis-
ease allele frequency was set at 0.0025; penetrances were
0.01, 0.5, and 0.5 for those with SRS scores in the spec-
trum category and 0.0014, 0.8, 0.8 for those with SRS
scores in the SRS affected category. Nonparametric
methods provide an analytic approach independent of
model assumptions. However, for the analysis of
extended pedigrees, the parametric approach may be
preferable. Parametric analysis provides assumptions
about the genotype-phenotype relationship, simplifying
the parameter space and allowing for more powerful and
efficient analyses without increasing the false positive
rate [22,50,51]. The multipoint heterogeneity LOD score
(HLOD) allows for a proportion of unlinked pedigrees (1-
alpha) and variation in the recombination fraction. The
H L O D  p r o vi d ed  b y  M CL I N K  i s  r o b u s t  t o  m od e l  m i s -
specification and may reflect the true position of linkage
peaks more accurately under conditions of appreciable
heterogeneity [47,50,52]. HLOD scores have been shown
to be more powerful than homogeneity LOD scores or
model-free methods under these conditions [52,53]. The
HLOD has been shown to produce scores consistent with
other published methods [47,54]. P-values from the non-
parametric qualitative analyses were converted to LOD
scores for ease of interpretation and comparison with the
parametric results. We present results in the commonly
used framework of significance thresholds proposed by
Lander and Kruglyak [55]: LOD score ≥ 1.88 (P = 0.0017)
represents suggestive evidence and LOD score ≥ 3.30 (P =
0.000048) represents significant evidence. We recognize
that our study design does not match perfectly with the
design that generated these thresholds but they do pro-
vide reasonable benchmarks which enable us to organize
and present our data. All P-values are theoretical, not
empirical.
In order to analyse the SRS as a quantitative trait, we
first applied a square root transform the SRS data to
adjust for non-normality in the distribution, as has been
done with previous SRS analyses [17]. The effects of age
and gender were partialled out using regression.
MCLINK was used to perform parametric quantitative
trait analysis. In a quantitative trait analysis there is no
concept of 'affected' or 'unaffected'; all individuals with aCoon et al. Molecular Autism 2010, 1:8
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trait value are included in the analysis, other individuals
are considered unknown. The MCLINK nonparametric
analysis considers quantitative similarity among relatives
and has been previously described [56]. For the paramet-
ric quantitative analysis, the penetrance vector for an
individual is based on their observed trait value and three
specified trait distributions for the three genotypes at the
disease locus (no risk allele, one risk allele, two risk
alleles). The three trait distributions are unknown, but
can be estimated from the observed trait data. The SRS
score cutoffs provide theoretical categories of unaffected,
spectrum and affected subjects. Here we considered
these three categories as a representing a hypothetical
genetic model of: no risk allele, one risk allele and two
risk alleles, and means and standard deviations of
adjusted SRS scores were estimated. The three distribu-
tions for zero, one or two risk alleles were specified to be
normal distributions with means of -1.552, 1.184, and
2.558 and standard deviations of 2.238, 1.581, and 1.356,
respectively. The penetrance vector for an individual is
simply the relative probabilities of the trait being
observed from the three distributions. Only the relative
probability between the three penetrance values is impor-
tant as the linkage statistic is a likelihood ratio. For effi-
cient calculation of parametric quantitative LOD scores,
the continuous penetrance function is discretized into
multiple classes (here, 40) and all individuals with trait
values residing in a class are assigned penetrance vectors
at the mid-point of the class. Classes were defined start-
ing -3SD below the mean of the zero risk alleles distribu-
tion and adding equal increments to reach +3SD above
the mean of the two risk alleles distribution.
In summary, we note that use of the SRS results in three
important differences between this analysis and our pre-
vious affected-only analysis using clinical diagnosis on
these families. First, this analysis includes information
from an additional 337 clinically unaffected relatives.
Second, for the qualitative analysis, affection status was
defined using SRS data rather than clinical measures.
Third, a quantitative analysis uses a full range of scores on
autism-related traits in all measured pedigree members.
Results
Table 2 describes the diagnostic information for affected
subjects. Of the 181 total affected subjects included in
this analysis, 165 had data on both the ADI-R and ADOS-
G; 16 other cases were assigned a diagnosis based on cri-
teria specified in Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV-TR criteria). One hundred
and thirty-five affected subjects met criteria for strictly
defined autistic disorder (AD) and 46 met criteria for an
ASD. There was a 7.4:1 male:female ratio among the sub-
jects with strictly defined autism, which fell to 3.6:1
among the subjects with an ASD. For all subjects com-
bined, the male:female ratio was 5.96:1. As expected,
ADI-R scores were significantly higher for the autism
group compared to the ASD group (t = 8.19, P < 0.0001
for social; t = 6.95, P < 0.0001 for verbal; t = 2.95, P =
0.004 for restricted interests/repetitive behaviours). The
nonverbal total cannot be compared because no ASD
s u b j e c t s  w e r e  n o n v e r b a l .  Q u a n t i t a t i v e  s c o r e s  o n  t h e
ADOS are not compared because of differences between
modules but significantly more individuals in the autism
group were administered Modules 1 and 2 compared to
the ASD group.
Regression adjustment of the SRS for age and gender
effects resulted in parameter estimates of -0.074 for age
and 1.6 for gender (males have higher scores). Figure 1
gives the distribution of SRS scores by diagnostic cate-
gory. SRS scores were significantly different between
autism and ASD (t = 3.71, P = 0.0003) and between ASD
and other relatives (t  = 10.57, P  < 0.0001). Among
affected subjects, substantial correlations were observed
between ADI domain scores and the SRS total score. The
highest correlations were observed with the ADI social
domain score, with a correlation of 0.60 among ASD sub-
jects and a correlation of 0.46 among subjects with AD.
For ASD subjects, 17.1% scored in the normal range on
the SRS, 39.0% scored in the spectrum range and 43.9%
scored in the affected range. Among subjects with a clini-
cal diagnosis of autism, 5.6% scored in the normal range,
19.1% scored in the spectrum range and 75.4% scored in
the affected range. The 95 genotyped spouse pairs
showed a significant spouse correlation of 0.33 (P  =
0.001) using the square root transformed adjusted scores.
The genome-wide analyses of the data are summarized
in Table 3 and in Figures 2 and 3. Note that MCLINK
does not provide NPL scores for the X chromosome.
Qualitative analyses show substantial overlap with our
previous affected-only genome-wide study of these same
families [32], in addition to revealing new positive results.
We also saw positive findings from our analysis of the
quantitative SRS data and replicated the chromosome 11
SRS finding reported by Duvall et al. [20].
Figure 4 shows results for individual chromosomes
where peaks overlap previous findings. The most signifi-
cant peak was found in the MCLINK qualitative nonpara-
metric analysis, with a genome-wide significant LOD
score of 3.64 on chromosome 15q13.3 at rs1026752
(31,177,959 bp). Note that we converted all nonparamet-
ric linkage (NPL) scores to LOD scores for ease of com-
parison. The MCLINK recessive model maximized at the
same location with a suggestive score of 3.07. This peak
extended from about rs1719013 to rs580839 (27,940,000
bp - 32,780,000 bp). This peak was in the same location as
the most significant linkage peak from our affected-only
genome scan using clinical affection status in these pedi-
grees [32].Coon et al. Molecular Autism 2010, 1:8
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We also saw evidence for linkage in other locations (see
Table 3 and Figures 3 and 4). Of these peaks, those on
chromosomes 7q31.1-q32.3 and 13q12.3 were also found
in our previous genome scan using clinical affection sta-
tus [32]. The peak at 7q31.1-q32.3 (125,450,000 bp -
130,300,000 bp) showed consistent evidence between
quantitative and qualitative analyses. The 13q12.3 peak
also showed overlap with our previous clinical diagnosis
s c a n .  I n  t h e  c u r r e n t  s t u d y ,  t h i s  p e a k  e x t e n d e d  f r o m
26,500,000 bp to 33,000,000 bp and was supported by the
qualitative recessive analyses. A second apparently dis-
tinct peak was found on chromosome 13q32.1 at
94,452,168 bp, also in the qualitative recessive analyses.
Our most significant quantitative peak was on chromo-
some 7q (LOD = 2.91) in the same region as the evidence
from the qualitative analyses. Our next most significant
peak was on chromosome 11p15.1-p15.4 spanning a
region from 7,300,000 bp to 22,400,000 bp, with a maxi-
mum LOD of 2.77 at two adjacent SNPs (rs214101 and
rs4757574) from a parametric analysis. The base pair
location of our peak (17,246,930 bp - 17,682,950 bp, or
25.59cM - 26.84 cM) is well within one of the most signif-
icant peaks previously reported by Duvall et al. [20] in
their quantitative SRS scan. Other quantitative peaks
were found on chromosomes 9p24.3 and 19q13.43. The
9p24.3 peak is in a region previously identified in a clini-
cal diagnosis scan done in our first extended family
[44,57].
Discussion
The present genome-wide linkage scan of SRS scores was
performed using 518 relatives from a unique resource of
large extended and smaller multiplex ASD families from
Utah. We found genome-wide significant linkage on
chromosome 15q13.3, and several other suggestive find-
ings. Peaks on chromosomes 7q, 13q and 15q were also
found in our previous genome scan of affected-only sub-
jects in these families based on clinical diagnosis [32].
SRS quantitative analyses also replicated a finding on
chromosome 11 p reported in a previous genome scan of
the SRS [20], providing some evidence for genetic consis-
tency of this measure used as a quantitative trait across
studies.
Table 2: Descriptive information for pedigree subjects.
Mean ADI domain scores (SD; N)
Diagnostic 
group
N Male: female IQ > 70 (%) Mean age 
(SD)
Mean 
SRS 
score 
(SD; N; % 
child 
version)
Social Verbal Non-verbal Restr/
Repet
Autism* 135 119:16 (7.44:1) 69/125 
(55.2)
13.87 
(11.44)
107.0 (31.4; 
N = 126; 
75.4%)
21.8 (6.4) 17.2 (4.7) 12.3 (2.3; N = 26) 6.7 (2.6)
ASD† 46 36:10 (3.60:1) 37/43 (86.1) 16.98 
(15.25)
86.4 (29.1; N 
= 41; 75.6%)
12.7 (5.9) 10.5 (6.4) (N = 0) 5.3 (2.9)
All affected 
subjects
181 155:26 (5.96:1) 106/168 
(63.1)
14.64 
(12.51)
101.9 (33.5; 
N = 167; 
75.5%)
19.5 (7.5) 15.2 (6.1) 12.3 (2.3; N = 26) 6.3 (2.7)
All relatives 
with no 
ASD 
diagnosis
448 211:237(0.9:1) 37.30 
(20.49)
28.7 (24.0; N 
= 351; 
22.5%)
* 11 cases were missing an Autism Diagnostic Interview (ADI); five cases were missing an Autism Diagnostic Observation Schedule.
† Three cases were missing an ADI; no cases were missing an ADOS.
SD, standard deviation; SRS, Social Responsiveness Scale; Restr/Repet, Restricted Interests/Repetitive Behaviors Domain ScoreCoon et al. Molecular Autism 2010, 1:8
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The SRS was developed as a continuous measure of
autistic traits, with variation intended to extend across
affected subjects and unaffected relatives. Among
affected subjects, our data suggest substantial correla-
tions between clinical measures of autism from the ADI
and SRS total scores, particularly for the social behav-
ioural domain. ADI and SRS are expected to differ to
some degree because ADI scores are based on informa-
tion from the developmental period between ages 4-5 and
also on the most severe presentation through the individ-
ual's life, while the SRS focuses on current behaviour. In
addition, most clinically affected subjects scored in the
s p e c t r u m  o r  a f f e c t e d  r a n g e s  o n  t h e  S R S ,  t h o u g h  a s
expected, we observed a substantial range of scores. Most
of the clinically unaffected relatives scored in the normal
range on the SRS (87.4%), but considerable variation also
occurred in these scores.
In our previous genome-wide scan, all relatives with no
clinical diagnosis were considered unknown, so results
were based on phenotypic information from 192 geno-
typed affected cases. Using the SRS in the present study,
we added information for 337 clinically unaffected rela-
tives, though 11 clinically affected subjects from the pre-
vious scan were missing SRS scores and were not
included here. A small percentage of clinically diagnosed
relatives (N = 14) scored within the normal range on the
SRS and therefore also contributed different information
to the current scan. Our families also replicated previous
evidence for significant SRS spouse resemblance (r  =
0.33, P = 0.001) [17].
The new information provided by the SRS in these fam-
ilies revealed additional findings beyond our previous
affected-only clinical diagnosis scan [32]. Not surpris-
ingly, given the overlap in classification of affected sub-
jects based on the SRS or the ADI/ADOS, the best
overlap in findings between the current study and our
previous study resulted when the SRS was treated as a
qualitative trait. The use of a SRS-defined spectrum cate-
gory and the addition of information from other clinically
unaffected relatives provide the primary difference in
findings between this study and our previous clinical
diagnosis scan. The investigation of the whole range of
quantitative information produced additional results,
which again is perhaps not surprising. We used paramet-
ric quantitative methods in an effort to increase the simi-
larity between qualitative and quantitative analyses. We
realize that multiple tests may have increased our
chances of a false positive result. If we conservatively
assume that models are uncorrelated, our significance
thresholds would be adjusted by log10(5) = 0.7 LOD score
units [58] for these five tests: dominant, recessive, NPL
qualitative tests and parametric and NPL quantitative
tests.
Our genome-wide significant result on chromosome
15q13.3 was supported by the qualitative NPL and reces-
sive models and some lesser evidence also by the quanti-
t a t i v e  a n a l y s i s  ( s e e  F i g u r e  4 ) .  I n  o u r  p r e v i o u s  g e n o m e
scan our best results also occurred on chromosome 15q
in three locations that may represent a single peak
(29,459,872 bp, 36,837,208 bp, and 55,629,733 bp) [32].
Liu et al. [27] have also reported evidence for linkage in
this region (LOD = 4.01 at 15q13.3-q14).
The region on chromosome 7q31.3-32.3 also occurred
in our previous clinical diagnosis scan, and was sup-
ported consistently across analysis models. This peak
(125,450,000 bp - 130,300,000 bp) has been implicated
previously by other studies [59-63]. Our findings suggest
that SRS information strengthened this peak over the 7q
peak in previous clinical diagnosis scan (LOD = 1.97),
though results here are still only suggestive (LOD = 2.91).
W e note that the CNTNAP2 gene of recent interest in
autism [64] is at 145,444,386 bp, downstream of our peak.
The final peak showing overlap with our clinical diagno-
sis scan was on 13q12.3. A second downstream peak at
13q32.1 appeared in the current SRS study that was not
Figure 1 Histograms of Social Responsiveness Scale scores for 
subjects in Utah autism pedigrees.
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evident in the clinical diagnosis scan. While some studies
have reported positive findings on chromosome 13 for
autism, attention has focused on the neurobeachin gene
(NBEAL2) [65], which lies in between our two regions
and is, therefore, not supported by our data.
Other peaks were observed on chromosomes 6 and 10.
The regions on chromosome 6p25.3 and 6p22.1 have
appeared in schizophrenia studies [66-68] and also in
bipolar disorder [69,70]. The region also harbors a copy
number variation (CNV) at 27,827,354-28,119,631 impli-
cated in autism [71]. Interestingly, chromosome 10p12.1
and 10q22.1-q22.2 also has been reported for schizophre-
nia and bipolar disorder in many of the same samples that
showed chromosome 6 findings [69,72-74]. Somewhat
strikingly, two genome-wide associations with attention
deficit and hyperactivity disorder (ADHD) have also been
found on chromosome 10p12.1 at 27,672,044-27,694,523
and 10q22.1 at 72,126,813-72,120,519 [75]; both findings
are quite close to our linkage peaks. Additional evidence
Table 3: Linkage results with P-values ≤ 0.0017 (suggestive evidence) for at least one method of analysis from quantitative 
and qualitative analyses of the total Social Responsiveness Score (SRS). 
Chromosome Location1 Score (alpha2; P-value) Phenotype, model
6p25.3 133,969 1.93 (0.40; 0.0014) Qualitative, recessive
6p22.1 26,261,314 2.36 (0.31; 0.00049) Qualitative, recessive
7q31.1-q32.3 113,934,453 2.07 (0.54; 0.001) Quantitative, parametric
129,451,548 2.91 (--; 0.00013) Quantitative, NPL
130,291,151 2.55 (0.37; 0.00031) Qualitative, recessive
9p24.33 593,192 2.66 (0.75; 0.00023) Quantitative, parametric
10p12.1 27,770,267 2.03 (0.74; 0.0011) Qualitative, dominant
10q22.1-q22.2 76,287,863 1.88 (0.65; 0.0016) Qualitative, dominant
11p15.1-p15.44 12,519,296 2.77 (0.44; 0.00018) Quantitative, parametric
13q12.3 30,070,594 2.23 (0.60; 0.00068) Qualitative, recessive
13q32.1 94,452,168 2.14 (0.85; 0.00085) Qualitative, recessive
15q13.3 31,177,959 3.64 (--; 0.000021) Qualitative, NPL
31,177,959 3.07 (0.70; 0.000085) Qualitative, recessive
19q13.43 59,338,102 2.14 (0.71; 0.00085) Quantitative, parametric
Bold font indicates significant evidence (P ≤ 0.000048).
Note: All nonparametric linkage (NPL) scores have been converted to equivalent logarithm of the odds (LOD) scores. Chromosomal locations 
indicated in italics overlap our affected-only genome scan using clinical diagnosis [32].
1 Location at the maximum of the peak.
2 Alpha, the estimated proportion of linked families for the MCLINK heterogeneity LOD score, is given for parametric analyses.
3 The peak at 9p24.3 is in the same location as a peak reported in a single family from our sample [35].
4 The peak at 11p15.1-p15.4 replicates previous genome scan results of quantitative SRS scores [20].Coon et al. Molecular Autism 2010, 1:8
http://www.molecularautism.com/content/1/1/8
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Figure 2 Genome scan results of Social Responsiveness Scale scores treated as qualitative categories (unaffected, spectrum, and affected) 
using MCLINK. (a) The nonparametric analysis does not assume a genetic model; scores for this analysis have been converted to logarithm of odds 
(LOD) scores for ease of comparison. Analyses were also performed using basic recessive (b) and dominant (c) models with parameters consistent 
with the prevalence of autism spectrum disorder.
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exists in two other samples of an association between
ADHD and autism using the SRS [76,77].
A quantitative analysis also revealed findings of inter-
est. While results using the quantitative range of the SRS
often paralleled the qualitative findings, there were inter-
esting exceptions. We note that while we used the same
genetic analysis software, the variation in the trait was
treated quite differently, so direct overlap of findings
would not necessarily be expected. For the quantitative
analysis, we also note that adjusting for age and gender
may have been a conservative adjustment, as clinical
affection status is associated with age and gender. As a
result of this adjustment, our quantitative results are
unlikely to be due to behaviours that change with age or
behaviour specific to gender. Our highest quantitative
peak was on chromosome 7 in the same region as
described above. Our next highest quantitative peak was
on chromosome 11p15.5-p15.4, spanning a region from
7,300,000 bp to 22,400,000 bp (12.11 - 37.63 cM). This
peak replicates a previously reported SRS peak from 15-
45 cM found in an analysis of quantitative SRS scores
[20]. Liu et al. [27] also found linkage in this region, pri-
marily using a phenotype of delayed phrase speech, but
with supporting evidence also from other phenotypes. A
Figure 3 Genome scan results of quantitative Social Responsiveness Scale (SRS) scores using MCLINK. The nonparametric analysis (a) does not 
assume a genetic model, and scores were converted to logarithm of odds (LOD) scores for ease of comparison. The parametric analysis (b), assumes 
the penetrance vector for an individual is based on their observed trait value and three specified trait distributions for the three genotypes at the dis-
ease locus (no risk allele, one risk allele, two risk alleles). These trait distributions are assumed to map onto the SRS score cutoffs (unaffected, spectrum, 
and affected). The penetrance vector for an individual is the relative probabilities of the trait being observed from the three distributions.
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previous genome scan of clinical diagnosis in 1181 multi-
plex families also identified this region [78]. On chromo-
some 19q13.4, our quantitative evidence spanned a
region from 57,150,000 bp to 63,780,000 bp. This region
overlaps with previous autism linkage evidence [79] and
also has several CNVs associated with autism [71].
Finally, we observed peaks in two other regions previ-
ously identified in our families in scans using affection
status. We observed a quantitative peak on chromosome
9p24.3, from the telomere to about 4,330,000 bp. This
peak has been previously reported for obsessive compul-
sive disorder (OCD) [80,81]. The glutamate transporter
genet SLC1A1 is near this region (4,480,000 bp -
4,580,000 bp), and has shown some association with
OCD [82,83].
While it is important to seek replication of these find-
ings in independent samples, we intend first to pursue
these findings within our sample families. It is possible
that findings may be unique to our family sample; indeed,
a rare genetic finding for autism would be our expecta-
tion. However, if we can find genetic variation responsi-
ble for these statistical findings, the results may still
provide relevant evidence regarding biological mecha-
nisms and genetic pathways implicated in autism. Our
family data will allow us to investigate segregation of the
genetic variants responsible for these peaks and to deter-
mine more detailed associations with phenotypes related
to autism. The extended family design allows a more
powerful tool to investigate rare genetic variants in rela-
tion to phenotype than the genome-wide association
study design.
Conclusions
In summary, our results highlight three important points.
First, using a quantitative analysis, we replicated a previ-
ously reported SRS peak on chromosome 11 peak found
in the AGRE family sample [20]. This replication sup-
ports the SRS as a robust measure, as replication
Figure 4 Detail of levels of detail (LOD) score results on chromosomes 7, 11, 13, and 15. Scores of nonparametric linkage (NPL) analyses have 
been converted to LOD scores in order to facilitate comparisons.Coon et al. Molecular Autism 2010, 1:8
http://www.molecularautism.com/content/1/1/8
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occurred across independent samples, and in spite of dif-
ferences in study design and measurement. Our sample
included large extended pedigrees and more than half the
SRS scores in our sample were on adults; the Duvall et al.
study [20] included only measurements on children. Sec-
ond, our genome scan of SRS scores revealed several
peaks that were the same as those found in our previous
affected-only genome scan of clinical diagnosis [32].
These peaks in our Utah families are therefore robust to
the inclusion of data from clinically unaffected relatives
and to the analysis of autism measured in a manner quite
different from the traditional structured interview and
observation methods. This study supports our previous
ASD linkage findings and suggests the SRS may be a rea-
sonable surrogate measure for genetic analysis of ASD,
though the SRS does not provide the depth of informa-
tion used in a clinical setting. Finally, both qualitative and
quantitative analyses of SRS scores revealed linkage peaks
not observed using clinical affection status in our own
previous pedigree studies, but often overlapping with
other evidence from autism, ADHD, OCD, schizophrenia
and/or bipolar studies. These results indicate that the
additional information available from clinically unaf-
fected relatives and the information in the SRS itself may
reveal locations for autism susceptibility genes that would
not otherwise be detected.
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